<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
15:14
Users who purchase road tax online may incur significant additional fees. CNAIR recommends purchasing only from the official portal.
15:03
The police in Covasna discovered 130 cannabis plants following a raid in the village of Dalnic.
14:53
The government has adopted the Risk Preparedness Plan in the field of electricity, allowing Transelectrica to limit the consumption of large companies.
14:44
The open society and its narrative enemies
14:41
A man vandalized a rock on the Transfăgărășan, drawing a heart with his girlfriend's name. The police and the Environmental Guard from Argeș are looking for him to impose a fine.
See more news